The PI3K-AKT-mammalian target of rapamycin (mTOR) pathway is another important downstream cascade in Ph-positive leukemia, including CML and ALL. The gene discussed is AKT1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.